Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Milestone Pharmaceuticals Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
MIST
Nasdaq
2830
www.milestonepharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025
- Feb 11th, 2025 1:00 pm
Loss-Making Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Expected To Breakeven In The Medium-Term
- Feb 3rd, 2025 2:59 pm
Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC
- Jan 28th, 2025 1:00 pm
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Jan 7th, 2025 1:00 pm
Milestone Pharmaceuticals to Present at the Piper Sandler 36th Annual Healthcare Conference
- Nov 25th, 2024 1:00 pm
After Golden Cross, Milestone Pharmaceuticals (MIST)'s Technical Outlook is Bright
- Nov 19th, 2024 2:55 pm
Milestone Pharmaceuticals: Q3 Earnings Snapshot
- Nov 12th, 2024 2:17 pm
Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
- Nov 12th, 2024 2:03 pm
Individual investors account for 54% of Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) ownership, while institutions account for 46%
- Oct 9th, 2024 10:56 am
Milestone Pharmaceuticals to Host Investor KOL Event
- Sep 24th, 2024 12:00 pm
Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China
- Sep 6th, 2024 11:00 am
Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
- Sep 4th, 2024 12:00 pm
Milestone® Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Sep 3rd, 2024 12:00 pm
Milestone® Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024
- Aug 26th, 2024 12:00 pm
Milestone Pharmaceuticals: Q2 Earnings Snapshot
- Aug 8th, 2024 8:41 pm
Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
- Aug 8th, 2024 8:17 pm
Milestone® Pharmaceuticals to Present at the Upcoming BTIG Virtual Biotechnology Conference
- Jul 31st, 2024 12:00 pm
Milestone Pharmaceuticals Refreshes Board of Directors
- Jul 15th, 2024 12:00 pm
Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspectives on PSVT in the Community Setting” on June 20, 2024
- Jun 12th, 2024 12:00 pm
It Looks Like Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO May Expect Their Salary To Be Put Under The Microscope
- Jun 7th, 2024 11:38 am
Scroll